A domestically developed gene-editing therapy has successfully treated patients with beta-thalassemia, allowing them to live ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is included among the Top 10 Reddit Stocks That Will Skyrocket. On April 10, Morgan Stanley raised its price recommendation on Vertex Pharmaceuticals ...

The only gene-editing therapy approved for beta-thalassaemia at present is Vertex Pharma's CRISPR-based Casgevy ...

Researchers to examine the long-term effects of sickle cell disease, beta thalassemia, and acute leukaemias by linking health records across England: United Kingdom Friday, April ...

All five patients in the trial received CS-101, a treatment developed by Chinese researchers, and achieved fast hematopoietic reconstruction. This process allows the body to restart its blood-making ...

I am deeply humbled by the decades of support from people around the world. It is an honor to share this painful yet ...

NANNING -- In a milestone for genetic medicine, researchers in China have reported the world's first clinical success using a ...

With 2,000–2,500 severe thalassemia cases diagnosed each year in Vietnam, expanded access to stem cell transplantation is ...

This precision genetic medicine developer reported a notable insider sale as it advances therapies for rare and serious ...

CRISPR Therapeutics (NASDAQ: CRSP) is a pioneering biotech company, but it isn't yet a profitable one. That's why its shares ...

Durable expression of anti-sickling fetal hemoglobin and reduction in sickle hemoglobin ob ...

The experimental treatment would use CRISPR, a gene-editing tool likened to biological scissors, to make precise cuts in the ...